When the FDA reclassified interbody fusion devices in 2007, the C-Ti was the first such device to be cleared and now it is the first interbody fusion device to be cleared as an anterior cervical plate.
Read RSB Spine’s release on FDA approval of its InterPlate C-Ti.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
